Chargement de la fiche…
Chargement de la fiche…
Praticien hospitalier
Photo : Wolfgang Staudt from Saarbruecken, Germany, CC BY 2.0, Wikimedia Commons
Dans les médias
Vous êtes Dr Cedric Lukas ? Présentation, expertises, actes, site du cabinet : faites de cette fiche la page de votre cabinet.
Configurer votre fiche gratuitement →Dr Cedric Lukas est rhumatologue à Montpellier (34295). Il consulte à HOPITAL LAPEYRONIE CHU MONTPELLIER, 371 Avenue DU DOYEN GASTON GIRAUD, 34295 Montpellier.
Consulter
HOPITAL LAPEYRONIE CHU MONTPELLIER
371 Avenue DU DOYEN GASTON GIRAUD, 34295 Montpellier
Dr Cedric Lukas, c'est vous ?
Faites de cette fiche la page de votre cabinet.
Hospitalier
Pour aller plus loin
Remboursement
Pratique
Thèmes de publication
Domaines déduits des publications référencées sur PubMed.
Faits issus de registres publics et des déclarations du praticien — aucun classement.
DES Rhumatologie · Rhumatologie (SM) — Diplôme d'études spécialisées
DE Docteur en médecine — Capacité / certificat d'études spéciales
Les plus citées
2021Stem cell research & therapy79 citations
Curcumin-primed human BMSC-derived extracellular vesicles reverse IL-1β-induced catabolic responses of OA chondrocytes by upregulating miR-126-3p
2022Rheumatology (Oxford, England)53 citations
Rheumatoid arthritis is associated with increased gut permeability and bacterial translocation which are reversed by inflammation control
2022Joint bone spine52 citations
2022 French Society for Rheumatology (SFR) recommendations on the everyday management of patients with spondyloarthritis, including psoriatic arthritis
Contenus publics où le nom du praticien apparaît (YouTube, Google Actualités).
En bref
Dr Cedric Lukas consulte à HOPITAL LAPEYRONIE CHU MONTPELLIER, 371 Avenue DU DOYEN GASTON GIRAUD, 34295 Montpellier. Adresses issues de l'Annuaire Santé (ANS).
Par téléphone au 04 67 33 67 33 (numéro publié à l'Annuaire Santé). Un lien de recherche Doctolib est proposé sur cette page : si le praticien y est inscrit, son profil figure normalement parmi les résultats.
Identité, diplômes et lieux d'exercice : Annuaire Santé (ANS, licence ouverte). Conventionnement et carte Vitale : Assurance Maladie. Publications : bases scientifiques publiques (PubMed, HAL, OpenAlex), affichées seulement si le nom du praticien figure parmi les auteurs. Le praticien peut corriger sa fiche ou en demander le retrait à tout moment ; en cas d'homonymie, signalez-le.
Autour du cabinet
Rhumatologues à Montpellier →Rhumatologues en Hérault (34) →
Vous pouvez aussi demander le retrait de la fiche.
Aperçu de votre présentation
Rhumatologue à Montpellier, j'accompagne…
Exemple : vous choisissez vos propres domaines.
Adherence to Biologics and Psycho-cognitive Factors in Axial Spondyloarthritis: A Multicentric Cross-sectional Study
2026Joint bone spinePubMed
Weight change and longitudinal disease activity in rheumatoid arthritis: A real-world cohort study
2026RMD openPubMed
Evaluation of pregnancy outcomes in patients with rheumatoid arthritis compared with the general population: results from a French national prospective and matched study
2025The Lancet. RheumatologyPubMed
Effect of a 1-month methotrexate delay on pneumococcal vaccine immunogenicity and disease control in patients with early rheumatoid arthritis (VACIMRA): an open-label randomised trial
2025Joint bone spinePubMed
Risk of cancer in patients with rheumatoid arthritis under tocilizumab: Data from the French national registry REGATE
2025ACR open rheumatologyPubMed
Polypharmacy in Early Rheumatoid Arthritis: Impact on Treatment Response and Adverse Event Risk in a multicenter French prospective cohort study
2025ACR open rheumatologyPubMed
Analysis of the Impact of Tofacitinib Treatment on Weight and Body Mass Index in Patients With Rheumatoid Arthritis
2024RMD openPubMed
Persistence of power Doppler ultrasonography-detected synovitis over 1 year of follow-up predicts poor prognosis in rheumatoid arthritis in clinical remission: the SONORE prospective longitudinal study
2023Arthritis care & researchPubMed
Risk of Cancer After Initiation of Targeted Therapies in Patients With Rheumatoid Arthritis and a Prior Cancer: Systematic Review With Meta-Analysis
2022Rheumatology (Oxford, England)PubMed
Rheumatoid arthritis is associated with increased gut permeability and bacterial translocation which are reversed by inflammation control
2022Rheumatology (Oxford, England)PubMed
Rheumatoid arthritis is associated with increased gut permeability and bacterial translocation which are reversed by inflammation control
2022Clinical and experimental rheumatologyPubMed
Trajectories in early rheumatoid arthritis related fatigue over 10 years: results from the ESPOIR cohort
2022Joint bone spinePubMed
Impact of multimorbidity on disease modifying antirheumatic drug therapy in early rheumatoid arthritis: Data from the ESPOIR cohort
2022Rheumatology (Oxford, England)PubMed
Risk of diverticulitis and gastrointestinal perforation in rheumatoid arthritis treated with tocilizumab compared to rituximab or abatacept
2021Arthritis care & researchPubMed
Most Appropriate Conventional Disease-Modifying Antirheumatic Drug to Combine With Different Advanced Therapies in Rheumatoid Arthritis: A Systematic Literature Review With Meta-Analysis
2021Clinical and experimental rheumatologyPubMed
Cardiovascular events and change in cholesterol levels in patients with rheumatoid arthritis treated with tocilizumab: data from the REGATE Registry
2021Journal of medical Internet researchPubMed
Use of eHealth by Patients With Rheumatoid Arthritis: Observational, Cross-sectional, Multicenter Study
2020The Journal of rheumatologyPubMed
Association Between Vitamin D Deficiency and Disease Activity, Disability, and Radiographic Progression in Early Rheumatoid Arthritis: The ESPOIR Cohort
2020Scandinavian journal of rheumatologyPubMed
Predictors of fatigue and persistent fatigue in early rheumatoid arthritis: a longitudinal observational study, data from the ESPOIR cohort
2026Joint bone spinePubMed
Efficacy and Tolerance of a Combination of Targeted Therapies Indicated for Asthma and Chronic Inflammatory Rheumatism
2026Rheumatology (Oxford, England)PubMed
Stability and prognostic value of B-cell markers in primary SS: results from the French ASSESS cohort
2023European radiologyPubMed
Sacroiliac joint MRI for diagnosis of ax-SpA: algorithm to improve the specificity of the current ASAS MRI criteria
2022CellsPubMed
Effects of Extracellular Vesicles from Osteogenic Differentiated Human BMSCs on Osteogenic and Adipogenic Differentiation Capacity of Naïve Human BMSCs
2021Stem cell research & therapyPubMed
Curcumin-primed human BMSC-derived extracellular vesicles reverse IL-1β-induced catabolic responses of OA chondrocytes by upregulating miR-126-3p
2021Joint bone spinePubMed
Head-to-head trials in inflammatory arthritis
2020Frontiers in bioengineering and biotechnologyPubMed
hBMSC-Derived Extracellular Vesicles Attenuate IL-1β-Induced Catabolic Effects on OA-Chondrocytes by Regulating Pro-inflammatory Signaling Pathways
2024Seminars in arthritis and rheumatismPubMed
Improvement in spinal pain at night and its impact on long-term outcomes in radiographic axial spondyloarthritis: Results from Ixekizumab COAST-V randomised trial
2024RMD openPubMed
Early clinical response associates with long-term outcomes with ixekizumab in radiographic axial spondyloarthritis
2024RMD openPubMed
Impact of the time of initiation and line of biologic therapy on the retention rate of secukinumab in axial spondyloarthritis (axSpA): data from the French multicentre retrospective FORSYA study
2023RMD openPubMed
Factors associated with the retention of secukinumab in patients with axial spondyloarthritis in real-world practice: results from a retrospective study (FORSYA)
2022RMD openPubMed
Impact of disease activity outcome measures reporting in the medical records of patients with axial spondyloarthritis on the retention rates of biological treatment: the example of secukinumab use in daily practice in France
2025Joint bone spinePubMed
Risk of cancer in patients with rheumatoid arthritis under tocilizumab: Data from the French national registry REGATE
2024RMD openPubMed
Risk of severe infection associated with immunoglobulin deficiency under rituximab therapy in immune-mediated inflammatory disease
2022Rheumatology (Oxford, England)PubMed
Risk of diverticulitis and gastrointestinal perforation in rheumatoid arthritis treated with tocilizumab compared to rituximab or abatacept
2021Clinical and experimental rheumatologyPubMed
Cardiovascular events and change in cholesterol levels in patients with rheumatoid arthritis treated with tocilizumab: data from the REGATE Registry
2026Rheumatology (Oxford, England)PubMed
One-month delay in MTX initiation on RA outcomes: 1-year ancillary analysis of the VACIMRA trial
2025The Lancet. RheumatologyPubMed
Effect of a 1-month methotrexate delay on pneumococcal vaccine immunogenicity and disease control in patients with early rheumatoid arthritis (VACIMRA): an open-label randomised trial
2022Joint bone spinePubMed
Erratum to "2022 French Society for Rheumatology (SFR) recommendations on the everyday management of patients with spondyloarthritis, including psoriatic arthritis" [Joint Bone Spine 2022;89:105344]
2022Joint bone spinePubMed
2022 French Society for Rheumatology (SFR) recommendations on the everyday management of patients with spondyloarthritis, including psoriatic arthritis
2026 · Article
Weight change and longitudinal disease activity in rheumatoid arthritis: a real-world cohort study
2026 · Article
Evaluation of pregnancy outcomes in patients with rheumatoid arthritis compared with the general population: results from a French national prospective and matched study
2026 · Article
Stability and prognostic value of B-cell markers in primary Sjögren’s syndrome: results from the French ASSESS cohort
2026 · Article
One-month delay in methotrexate initiation on rheumatoid arthritis outcomes: One-year ancillary analysis of the VACIMRA trial
2026 · Article
Evaluation of pregnancy outcomes in patients with spondyloarthritis compared to the general population: results from a French national prospective and matched study
2025 · Article
Effect of a 1-month methotrexate delay on pneumococcal vaccine immunogenicity and disease control in patients with early rheumatoid arthritis (VACIMRA): an open-label randomised trial
2025 · Article
Analysis of the Impact of Tofacitinib Treatment on Weight and Body Mass Index in Patients With Rheumatoid Arthritis
2025 · Article
Risk of cancer in patients with rheumatoid arthritis under tocilizumab: data from the French national registry REGATE
Publications affichées uniquement lorsque le nom du praticien figure parmi les auteurs. Une erreur d'homonymie ? Signalez-la depuis le lien en bas de page.